Shares of Ingevity Corporation (NYSE:NGVT – Get Free Report) have received a consensus recommendation of “Hold” from the five ratings firms that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $80.00.
Several equities analysts recently commented on NGVT shares. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Weiss Ratings raised shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st.
Get Our Latest Stock Analysis on Ingevity
Ingevity Stock Down 0.0%
Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.41. The company had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, research analysts expect that Ingevity will post 5.4 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, CEO David Li sold 5,000 shares of Ingevity stock in a transaction on Monday, August 17th. The shares were sold at an average price of $75.83, for a total transaction of $379,150.00. Following the completion of the sale, the chief executive officer directly owned 120,636 shares in the company, valued at approximately $9,147,827.88. The trade was a 3.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan Fisher sold 2,709 shares of the business’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the sale, the senior vice president directly owned 15,722 shares in the company, valued at $1,159,025.84. This trade represents a 14.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 17,801 shares of company stock valued at $1,347,481. Corporate insiders own 0.88% of the company’s stock.
Institutional Trading of Ingevity
Several large investors have recently added to or reduced their stakes in the company. Frazier Financial Advisors LLC acquired a new stake in shares of Ingevity during the second quarter worth about $37,000. Global Retirement Partners LLC acquired a new position in Ingevity in the 2nd quarter worth approximately $45,000. Harbor Investment Advisory LLC purchased a new position in Ingevity during the 2nd quarter worth approximately $71,000. Public Employees Retirement System of Ohio purchased a new position in Ingevity during the 2nd quarter worth approximately $75,000. Finally, Assetmark Inc. lifted its stake in Ingevity by 9.6% during the 1st quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock valued at $113,000 after acquiring an additional 139 shares during the period. Hedge funds and other institutional investors own 91.59% of the company’s stock.
About Ingevity
Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, sustainability and resource efficiency across a range of industrial and consumer applications. Its businesses serve automotive, infrastructure, industrial, agricultural and other end markets.
The company’s portfolio includes activated carbon products used in vehicle evaporative-emissions control systems, industrial air and water purification, and other filtration applications.
Featured Stories
- Five stocks we like better than Ingevity
- NVIDIA Just Named AI’s Next Bottleneck—And These 3 Stocks Sit Right In It
- Gold Has Gone Sideways, But These 3 Stocks Haven’t
- The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing In
- These 3 Stocks Under $20 Have Wall Street Looking Past the Share Price
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
